Huadong Medicine's (SHE:000963) net profit attributable to shareholders in the first half rose 2.5% to 1.86 billion yuan from 1.81 billion yuan a year earlier, according to a Shenzhen bourse filing on Thursday.
Earnings per share increased 2.6% year on year to 1.06 yuan from 1.03 yuan.
Operating revenue climbed 1.8% to 22.1 billion yuan from 21.7 billion yuan in the previous year.
The Chinese drugmaker proposed to distribute a cash dividend of 3.50 yuan per 10 shares to shareholders.
The company's shares rose 1% at the close.